EUVIMEDEUVIMED entdecken
Übersichtsarbeit

mRNA‑Encoded Antibodies as a Powerful Arsenal Against Superbugs‐Induced Sepsis

Shuchen Pei iD, Zhaofei Guo iD, Linlin Cheng, Mingxing Luo, Shan Guan iD, Lifeng Xu, Rui Liao, Qin Xiao, Wen Wu iD, Hao Zeng

Drug Development Research · 2026-12 · 87 (8)

DOI: 10.1002/ddr.70412 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Development Research, online erschienen am 15.11.2026. Verfasst von Shuchen Pei und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Chongqing University of Science and Technology, Chongqing, China. Hauptthemen laut MEDLINE: Sepsis, RNA, Messenger, Antibodies, Monoclonal. Die Arbeit nennt 79 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Science and Technology Major Project, Natural Science Foundation of Chongqing Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sepsis, a life‐threatening organ dysfunction triggered by a dysregulated host response to infection, represents a formidable global health crisis, exacerbated by the relentless rise of multidrug‐resistant (MDR) bacteria. Antibiotic treatment is increasingly challenged by antimicrobial resistance, and conventional monoclonal antibody (mAb) therapies face significant manufacturing and logistical hurdles. This review focuses on the use of messenger RNA (mRNA) as a programmable platform to turn the patient's own body into a bioreactor for producing therapeutic antibodies on demand. We explore the transformative potential of this strategy, which merges the precision of antibody therapy with the speed and flexibility of nucleic acid technology. We critically analyze the ground‐breaking preclinical evidence for mRNA‐encoded antibodies against key bacterial virulence factors, such as the Pseudomonas aeruginosa Type III secretion system (T3SS). Beyond direct pathogen neutralization, we propose a visionary dual‐pronged approach, combining anti‐pathogen mRNA with immunomodulatory strategies to simultaneously control infection and rebalance the dangerously chaotic immune response characteristic of sepsis. However, the path to clinical reality is fraught with challenges, including targeted delivery to systemic infection sites, the dearth of long‐term safety data, and the absence of a mature regulatory framework. We conclude by outlining a roadmap for the future, envisioning an era of multiplexed, personalized mRNA cocktails and artificial intelligence (AI)‐driven design, which could finally provide a potent and adaptable weapon in the war against superbug sepsis and multi‐organ failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SepsisRNA, MessengerAntibodies, MonoclonalHumansAnimalsPseudomonas aeruginosa

Stichwörter der Autor:innen

antibodyimmunomodulatoryin vitro transcribed mRNAmultidrug‐resistant bacteriasepsis

Substanzen

RNA, MessengerAntibodies, Monoclonal

Autor:innen und Institutionen

  • School of Chemistry and Chemical Engineering, Chongqing University of Science and Technology, Chongqing, China.
  • Department of Pharmacy, The Second Affiliated Hospital of Third Military Medical University, Chongqing, China.
  • National Engineering Research Center of Immunological Products, Third Military Medical University, Chongqing, China.
  • Department of Pediatrics, Ludwig-Maximilians University, Munich, Germany.
  • Chongqing Key Laboratory of High Active Traditional Chinese Drug Delivery System, Chongqing Engineering Research Center of Pharmaceutical Sciences, Chongqing Medical and Pharmaceutical College, Chongqing, China.

ORCID-Profile: Shuchen Pei, Zhaofei Guo, Shan Guan, Wen Wu

Förderung

  • National Natural Science Foundation of China
  • National Science and Technology Major Project
  • Natural Science Foundation of Chongqing Municipality
  • Natural Science Foundation of Chongqing

Zitieren

APA

Pei, S., Guo, Z., Cheng, L., Luo, M., Guan, S., Xu, L., Liao, R., Xiao, Q., Wu, W., & Zeng, H. (2026). mRNA‑Encoded Antibodies as a Powerful Arsenal Against Superbugs‐Induced Sepsis. Drug Development Research, 87(8). https://doi.org/10.1002/ddr.70412

Vancouver

Pei S, Guo Z, Cheng L, Luo M, Guan S, Xu L, et al. mRNA‑Encoded Antibodies as a Powerful Arsenal Against Superbugs‐Induced Sepsis. Drug Development Research. 2026;87(8). doi:10.1002/ddr.70412

BibTeX
@article{Pei2026,
  author = {Pei, Shuchen and Guo, Zhaofei and Cheng, Linlin and Luo, Mingxing and Guan, Shan and Xu, Lifeng and Liao, Rui and Xiao, Qin and Wu, Wen and Zeng, Hao},
  title = {mRNA‑Encoded Antibodies as a Powerful Arsenal Against Superbugs‐Induced Sepsis},
  journal = {Drug Development Research},
  year = {2026},
  volume = {87},
  number = {8},
  doi = {10.1002/ddr.70412}
}
Kostenlos starten →